• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Melatonin improves sleep onset in children with autism spectrum disorder

byRaahulan RathagirishnanandAshley Jackson
January 23, 2023
in Pediatrics, Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, sleep onset latency was significantly decreased in children with autism spectrum disorder who received melatonin compared to those who received placebo.

2. Furthermore, there were no serious adverse events or deaths associated with melatonin. The most common adverse events were infections, nervous system disorders, and pharyngitis.

Evidence Rating Level: 1 (Excellent)

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that can affect children’s social behaviours, cognitive aptitudes, and sleep quality. Exogenous melatonin is a known pharmacotherapy that is used to help improve sleep quality and has been studied in children with ASD. However, there has been limited evidence regarding the efficacy of this treatment. Therefore, the objective of this study was to investigate the safety and efficacy of exogenous melatonin for addressing sleep problems in children with ASD.

This randomized controlled trial conducted in Japan included outpatient children aged 6-15 years with ASD. Patients were included if they had a sleep onset latency (SOL) equal to or greater than 30 minutes and were cooperative for sleep hygiene interventions. Patients were excluded if they had severe intellectual disabilities, previous melatonin treatment, or breathing-related sleep disorders. Participants (n=229) were randomized to receive either 1-mg of melatonin, 4-mg of melatonin, or placebo 45 minutes before bedtime. SOL was measured by parents and caregivers using a sleep diary. Sleep actigraphy was also utilized for objective sleep measures, and adverse events were recorded. The primary outcome was the change in the median SOL from baseline.

Results demonstrated a significant reduction in SOL in both the 1-mg and 4-mg melatonin groups compared to the placebo group. Sub-group analyses in height, age, and weight were all significant for improvements in SOL in both 1-mg and 4-mg groups versus the placebo except of females in the 1-mg group. There were no serious adverse events or deaths, and the most common adverse events included infections, neurological disorders, and pharyngitis. However, a drawback of the study was the narrow inclusion criteria, which limited the generalizability of the results to children with ASD outside of the included age range. Nonetheless, this study identified melatonin as an effective intervention to improve sleep quality in children with ASD.

RELATED REPORTS

Short sleep duration associated with increased risk of diabetes

Cases of neurodevelopmental disorders caused by mutated lncRNA CHASERR

Poor sleep and elevation of liver function biomarkers may be predictive of liver cancer

Click to read the study in Journal of Autism and Developmental Disorders

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: autism spectrum disorderchildrenmelatoninneurodevelopmental disorderssleepwellness
Previous Post

2 Minute Medicine Rewind January 23, 2023

Next Post

Intranasal corticosteroids no better than saline in treating pediatric sleep-disordered breathing

RelatedReports

Career Development

Short sleep duration associated with increased risk of diabetes

March 14, 2025
Chronic Disease

Cases of neurodevelopmental disorders caused by mutated lncRNA CHASERR

November 25, 2024
Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males
Chronic Disease

Poor sleep and elevation of liver function biomarkers may be predictive of liver cancer

July 6, 2024
Pediatrics

Assessing between Sleep and Blood Pressure in Children and Adolescents

June 25, 2024
Next Post
Parents with poor sleep quality report sleep problems in kids

Intranasal corticosteroids no better than saline in treating pediatric sleep-disordered breathing

Patient Basics: Biliary Colic

Futibatinib for FGFR2 Mutated Intrahepatic Cholangiocarcinoma

School nurses essential in design and implementation of school safety programs

Combined visual-olfactory training for COVID-19 resultant olfactory loss

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
  • #VisualAbstract: Routine Cerebral Embolic Protection Did Not Reduce Stroke Incidence during Transcatheter Aortic-Valve Implantation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.